Chief Executive Officer, Kinomica
Jane Theaker is a companion diagnostics expert with a passion for using novel technologies, datasets and analytics to change the way we discover, develop and deliver drugs to patients. She has worked for the NHS, Zeneca Diagnostics, Astrazeneca, DxS, QIAGEN and the Laboratory of the Government Chemist (LGC). During her career Jane co-invented a real-time PCR technology at Zeneca Diagnostics that she and her team at QIAGEN later used to deliver FDA approved tests to support novel oncology drug launches. She was also an early proponent of NGS sequencing in Companion diagnostics. She now heads up Kinomica, a new start-up company, which uses a new, patented bioinformatics workflow called “KScan” to profile cell signalling networks, in order to accurately predict drug response. The KScan platform allows a snapshot of the whole cell signalling network (the phosphorylome) in a tissue to be generated and the most active kinases ranked so that appropriate drug treatments can be targeted.